🦠
MicroDAO Whitepaper
  • MICRO: Funding the next generation of AMR Solutions: Antimicrobials, Diagnostics, and Vaccines
    • Executive Summary
    • The AMR Challenge
      • Understanding Antimicrobial Resistance
      • The Human Innovation Gap
      • Investments into AMR solutions
    • microDAO: A Community-Driven Solution to Tackle AMR
      • Vision and Mission
      • Operational Framework
      • Structure of microDAO
        • Core Team
        • Community Members
        • Token Holders
        • Working Groups
        • Service Providers
        • Partners
        • End users of solutions and funding offered by microDAO
    • DAO Way of Working
    • microDAO’s Flywheel for Impact and Revenue: Community Tools and Workflows
      • Evidence Generation & Decision Support Tools
      • R&D Acceleration Tools
    • microDAO Revenue Streams: Building Sustainable Impact
    • Fund Allocation Strategy for liquid funds available in the DAO treasury
      • Strategic Priority Areas
        • Early-Stage Research Development
        • Clinical Development Support
        • Equitable Access Programmes
        • Infrastructure and Tools
        • Operational Sustainability
    • Impact and Future Outlook
Powered by GitBook
On this page
  1. MICRO: Funding the next generation of AMR Solutions: Antimicrobials, Diagnostics, and Vaccines
  2. microDAO’s Flywheel for Impact and Revenue: Community Tools and Workflows

R&D Acceleration Tools

These tools support specific development stages for each solution type as described below

Area

Example Use Cases

Antimicrobial Discovery and Development

Compound screening

Drug-target interactions

Predicting antimicrobial activity

Drug candidate Prioritisation

Vaccine Research and Development

Vaccine design

Antigenic drift analysis

Population-level immunity modelling

Vaccine coverage and distribution planning

Diagnostic Innovation

Developing and validating new diagnostics

Interpreting diagnostic test results

Assessing and comparing diagnostic test performance

Designing and optimising PCR-based diagnostics

Evaluating diagnostic strategies

PreviousEvidence Generation & Decision Support ToolsNextmicroDAO Revenue Streams: Building Sustainable Impact

Last updated 5 months ago